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ABSTRACT: G-Protein-coupled receptors (GPCRs) adopt various functionally relevant conformational states
in cell signaling processes. Recently determined crystal structures of rhodopsin and the 2-adrenergic
receptor (2-AR) offer insight into previously uncharacterized active conformations, but the molecular
states of these GPCRs are likely to contain both inactive and active-like conformational elements. We
have identiﬁed conformational rearrangements in the dynamics of the TM7-HX8 segment that relate to
the properties of the conserved NPxxY(x)5,6F motif and show that they can be used to identify active
state-like conformational elements in the corresponding regions of the new structures of rhodopsin and
the 2-AR.
G-Protein-coupled receptors (GPCRs) are integral mem-
brane proteins that share a seven-transmembrane (7-TM)
helix bundle architecture observed ﬁrst for rhodopsin (1–4)
and more recently for the 2-adrenergic receptor (2-AR) (5–7).
GPCRs respond to a diverse set of stimuli by switching
between conformational states, which enables coupling to
speciﬁc G-proteins as well as other intracellular binding
partners (8–12). There is evidence that most elements in the
spatially ordered series of conformational changes underlying
signal propagation within the TM domain are conserved
among rhodopsin-like GPCRs (8).
Experimental exploration of structural rearrangements
associated with activation have identiﬁed point mutations that
overcame constraints within the inactive forms and caused
constitutive activation (13–15). This led to the hypothesis
that some of the speciﬁc, constraining, interhelical interac-
tions within the TM domain that can be identiﬁed in the
crystal structures (1–7) represent elements of the activation
pathway (8). The required conformational rearrangements
have been shown to take advantage of another feature
considered to be conserved across the GPCR family, namely,
that the TM helices can incorporate structural perturbations
such as bends and kinks, induced by prolines or glycine pairs,
where protein ﬂexibility and hinge motions are enabled (16).
Together, such considerations led to the concept of
identiﬁable structural motifs (SMs) that are conserved across
the GPCR family and take on the role of functional
microdomains (FMs) (8, 9) working as modular units capable
of triggering changes in GPCR conformation and operating
as activation switches (17, 18). Therefore, a useful framework
for describing GPCR conformations associated with function
within a given receptor state can involve the systematic
assignment of a speciﬁc “state” to each FM.
Here we show that such a framework can be useful in
characterizing the functional phenotype of a particular GPCR
structure, such as in a crystal. For example, the recently
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Published on Web 06/18/2008determined crystal structure of rhodopsin (4) is thought to
be in some intermediate signaling state, and it would
therefore not be surprising to ﬁnd a set of elements, i.e.,
speciﬁc SMs and FMs, that are in an active-like state,
whereas others are inactive-like. Similarly, the molecular
state of the engineered 2-AR is ambiguous (5–7). This is
best illustrated by the ﬁnding that the TM3-TM6 salt bridge
is broken, a hallmark of activated GPCRs (7), yet the protein
is crystallized with an inverse agonist that prefers the inactive
state so that other regions of the protein may resemble the
inactive state represented by the original rhodopsin struc-
ture (1–4). In both cases, it should be useful to identify those
elements that belong to the activated phenotype, which is
the cumulative result of a superposition of active-like
components related to multiple SMs and FMs. Therefore,
we may ﬁnd that the static crystal structures exhibit some
such components, but not others.
We illustrate this novel procedure for the SM/FM com-
prised of TM7 and the juxtamembrane helix 8 (HX8) that
incorporates the widely conserved NPxxY(x)5,6F sequence
motif and has been shown to modulate GPCR activation,
phosphorylation, and internalization (19–22). Biophysical
experiments have demonstrated that both TM7 (23) and HX8
(24), which are seen in all of the GPCR crystals (1–7),
undergo conformational changes upon receptor activation,
suggesting that this SM/FM operates as an activation switch
utilized by many rhodopsin-like GPCRs.
In the inactive structure of rhodopsin, the side chains of
Y7.53 and F7.60 are close to each other (1–4), suggesting a
direct interaction. Mutations thought to disrupt this aromatic-
aromatic interaction, such as F7.60A, allowed formation of
an activated state of rhodopsin, Meta II, but without an
accompanying enhancement in G-protein activation (21). In
the rhodopsin-like serotonin 5-HT2C receptor, Asn substitu-
tion of Y7.53 was shown to yield a “locked-on” phenotype
in which the receptor has a maximal level of basal signaling
that is not reduced by an inverse agonist (19). Conversely,
mutation of Y7.53 to Phe in this GPCR leads to a “locked-
off” phenotype in which the level of basal signaling is
completely reduced and cannot be increased by an agonist.
Interestingly, the locked-off phenotype can be rescued by a
simultaneous Ala substitution at position 7.60. These experi-
ments highlight the interdependence of residues at positions
7.53 and 7.60 in modulating the transition to the active state.
Given the high level of structural similarity in this region
observed for the 2-AR (5–7) and rhodopsin (1–4) and
expected from the sequence identities, we speculate that
phenotype altering mutations within this SM/FM will produce
similar effects in many rhodopsin-like GPCRs, as shown for
other components of the activation pathway (8, 11).
Because a molecular description of the activation switch
involving these residues in GPCR function is still missing,
we used molecular dynamics simulations of wild-type (WT)
and mutant constructs (see Table 1) of rhodopsin embedded
in explicit models of hydrated lipid membranes to provide
mechanistic insight into how residues at positions 7.53 and
7.60 modulate receptor dynamics. With regard to the
experimentally determined phenotype altering mutations at
positions 7.53 and 7.60 of the rhodopsin-like 5-HT2C GPCR
(19), we studied the dynamic behavior of corresponding
rhodopsin mutants (Y7.53N, Y7.53F, F7.60A, Y7.53F/
F7.60A, and Y7.53N/F7.60A) with essential dynamics and
energy calculations to identify molecular indicators of their
functional phenotypes. An experimentally unexplored Y7.53N/
F7.60A construct was added to the study to investigate how
the locked-on phenotype of Y7.53N might be modiﬁed by
the F7.60A mutation that had rescued the inactive Y7.53F
mutant.
We ﬁrst examined the conformations explored by the
cytoplasmic end of TM7 and HX8 [from P303 (7.50) to C323
(7.70)], a segment termed TM7-HX8, using essential
dynamics (ED) analysis. ED analysis of structures from the
WT simulation (0-20 ns) produced eigenvectors describing
the directions of correlated motion. The fraction of the total
ﬂuctuation during this initial time interval contributed by the
eigenvector that had the highest corresponding eigenvalue
describes up to 33% of the overall ﬂuctuations for TM7-HX8,
at least twice as much as any other eigenvector. The same
analysis was conducted on structures taken from the last 20
ns of the simulation (25-45 ns) and compared with the
eigenvectors derived from the 0-20 ns segment. A calculated
inner product value of 0.91 indicated that the ﬂuctuations
described by the ﬁrst eigenvector persist throughout the
simulation, in contrast to motion described by other eigen-
vectors. Consequently, the ﬁrst eigenvector was chosen as a
reference vector in the conformational space against which
the sampling from the simulations of the mutant constructs
can be measured. The average structure of rhodopsin from
the WT simulation (0-20 ns) is shown in Figure 1A with
arrows assigned to each of the CR atoms of the TM7-HX8
segment pointing in the positive direction of the reference
eigenvector.
The degree of sampling of the reference conformational
space was measured by projecting the structures from each
simulation onto the ﬁrst eigenvector derived from the WT
simulation. To quantify these ﬁndings, the projections were
binned and plotted to represent a “projection proﬁle” for each
construct. Figure 1C shows that the projection proﬁles of
the WT and the F7.60A construct are both centered around
zero, with 47.1 and 44.3% of the conformations, respectively,
having projections with negative values. The projection
proﬁle of the Y7.53F mutant is dramatically different from
that of the WT with 77.2% of the conformations in the
negative direction. Notably, the Y7.53F/F7.60A construct,
which rescues the locked-off Y7.53F back to the WT-like
phenotype in the 5HT-2C receptor (19), has projections that
favor the positive direction, in the opposite direction from
Y7.53F. In contrast, the projection proﬁles from the simula-
tions of both the Y7.53N and Y7.53N/F7.60A constructs are
shifted rightward, to positive values (only 39.8 and 14.7%,
Table 1: Systems Studied with Molecular Dynamics Simulation and
Phenotypes Characterized Experimentally in 5-HT2C Receptors To
enhance robustness and verify reproducibility of the ﬁndings, the
simulations of the Y7.53F, F7.60A, Y7.53F/F7.60A,and Y7.53N
constructs of rhodopsin were repeated in triplicate by starting from the
same initial coordinates as the original simulations (26) but with
different initial random velocities
simulation time (ns) expected phenotype
wild type 45 wild type
F7.60A 12,10,10 slightly reduced activity
Y7.53F 20,14,14 “locked-off”
Y7.53F/F7.60A 12,10,10 similar to wild type
Y7.53N 20,14,14 “locked-on”
Y7.53N/F7.60A 12 unknown
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comparative analysis identiﬁes a metric capable of distin-
guishing the locked-on Y7.53N from the locked-off Y7.53F
and suggests that conformations along this eigenvector may
reﬂect phenotypically important changes in rhodopsin-like
GPCRs.
Using this metric, we examined the corresponding
TM7-HX8 segments within the most recently determined
GPCR crystal structures. The conformations of the TM7-HX8
segments from the photoactivated intermediate of rhodopsin
(4) were projected onto the eigenvector derived from the WT
simulation, in the same manner that was used for the
simulations of the mutant constructs. The projections for the
two available chains, B and C (chain A had unresolved
residues within this region), were both found to be 2.8-fold
greater than the mean square ﬂuctuation seen in the WT
trajectory along this eigenvector. These values are in the same
direction as the one favored in the simulation of the Y7.53N
construct, which corresponds to the activated (locked-on)
form of 5-HT2C (19). The structure of the photoactivated
intermediate thus exhibits dynamic properties more similar
to those of the Y7.53N construct than those of the Y7.53F
construct (which in 5-HT2C was shown to be locked-off).
A direct comparison with the corresponding segment from
the 2-AR structure (5–7) is complicated by the fact that the
linker between TM7 and HX8 is one residue shorter in the
2-AR, but the structural comparison with Figure 1B shows
that the TM7-HX8 segment of the 2-AR lies along the
same positive direction of the eigenvector we deﬁned, similar
to the locked-on Y7.53N construct and the photoactivated
intermediate of rhodopsin (4). Therefore, we conclude that
the TM7-HX8 segments in both of these GPCR crystal
structures resemble active-like conformational elements.
To reveal the intramolecular interactions that underlie the
speciﬁc dynamic behaviors identiﬁed for the TM7-HX8
segments in the various constructs, we calculated interaction
energies for the cytoplasmic half of TM7 with adjacent
helices, including TM1, TM2, TM6, and HX8 from all
simulations. The energies of interaction between TM7 and
TM1 were nearly the same for all of the constructs (data
not shown), with a standard deviation of only 5.2 kJ/mol
calculated from the averages of all of the constructs. The
same holds for the energies of interaction between TM7 and
TM6 with a standard deviation of 4.8 kJ/mol from the
averages of all of the constructs. This is not so for the energy
of interaction between TM7 and either TM2 or HX8, with a
total standard deviation of 16.8 or 12.6 kJ/mol, respectively,
and we are thus able to discriminate the states and conditions.
Surprisingly, it is not the TM7-HX8 interaction energy
(Figure 2A) that correlates best with the expected phenotypes
of the mutants (Table 1). This interaction energy remains
virtually identical in the WT and in the mutants that exhibited
the most dramatic phenotypes, locked-on Y7.53N and
locked-off Y7.53F. Only the F7.60A substitution, which had
little effect on the phenotype in 5-HT2C, signiﬁcantly
diminishes the energy of interaction between TM7 and HX8
(Figure 2A). The speciﬁc residue-residue interactions
between positions 7.53 and 7.60 are consistent with these
ﬁndings and show that the F7.60A mutation, but not Y7.53F
or Y7.53N, leads to a signiﬁcant loss of interaction energy
relative to that of the WT (Figure 2B), accounting for the
majority of the change in the energy of interaction between
TM7 and HX8. This argues against the possibility that the
mutations at positions Y7.53 and F7.60, which lead to
changes in rhodopsin conformation, do so by disrupting the
interaction between the two residues (21). Interactions among
other residues in this local environment are likely associated
with the phenotypes observed in 5-HT2C (19).
One such set of interactions affected by the mutations at
positions 7.53 and 7.60 is between TM7 and TM2 (Figure
2C). While all mutations of Y7.53 lead to a decrease in the
energy of interaction between these two regions, due to
disrupted 7.53 and N2.40 interactions (Figure 2D), in the
locked-on Y7.53N construct the interaction between 7.53 and
L2.43 is also weakened (Figure 2E), which results in a total
loss of 43 kJ/mol, i.e., 58% lower than WT. In contrast, the
TM7-TM2 interaction energy in both locked-off Y7.53F
and F7.60A is much less disrupted, being reduced by only
23 kJ/mol (31%) and 9 kJ/mol (12%), respectively, while
FIGURE 1: (A) Average structure of rhodopsin from the WT
simulation (0-20 ns) with arrows indicating the positive direction
of motion proportional to the mean square ﬂuctuation of each CR
atom along the reference eigenvector (the ﬁrst principal eigenvector
derived from the WT simulation) for the TM7-HX8 segment. (B)
TM7-HX8 segments from the photoactivated rhodopsin intermedi-
ate (yellow) and the 2-AR (red) ﬁtted onto the average structure
of inactive rhodopsin from the WT simulation (0-20 ns). CR atoms
for the sequence from position 7.50 to 7.57, and from position 2.40
to 2.43, were used to ﬁt the structures onto each other. Note that
these segments lie along the positive direction of the reference
eigenvector. (C) Projections of the TM7–HX8 segment from each
simulation onto the reference eigenvector, which is the ﬁrst principal
eigenvector derived from the WT simulation. The projections were
measured and binned starting from t ) 5 ns and represent the total
distribution from all corresponding trajectories for each construct
of rhodopsin (see Table 1). These distributions are plotted as the
fold change relative to the mean square ﬂuctuation of the WT
simulation along the reference eigenvector.
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relative to that of the WT. The magnitude of the TM7-TM2
interaction thus correlates roughly with the expected phe-
notypes of the 5-HT2C, suggesting that a severe disruption
of this interaction beyond a threshold (not reached in the
Y7.53F) is a feature of the activation transition. This
inference is mechanistically consistent with experiments that
found TM2 to be translated away from HX8, and TM7
translated away from TM1 upon photoactivation of rhodopsin
(23, 25). Therefore, we propose the magnitude of the
TM7-TM2 interaction as a property modulated by mutations
at positions 7.53 and 7.60 that contributes to the ﬁnal receptor
phenotype, in combination with the TM7-HX8 conforma-
tional sampling.
We examined the recently determined GPCR crystal
structures in light of our ﬁndings concerning the changes in
the TM7-TM2 interaction. One noted difference between
the 2-AR crystal structure and that of the inactive rhodopsin
crystal structures (1–3) is that the aromatic ring of Y7.53 in
the 2-AR is rotated away from HX8 and does not directly
interact with residues in TM2 (5–7, 18), as seen in Figure
2F. We can now interpret this change, as it is consistent with
weakened interactions between TM7 and TM2 observed in
the locked-on Y7.53N construct and supports our conclusion
that the conformation of this region of the 2-AR corresponds
to an active-like state. As for the interactions between TM7
and TM2 in the photoactivated intermediate of rhodopsin
(4), no obvious differences from the inactive models of
rhodopsin could be found, leading us to speculate that the
disruption in the TM7-TM2 interaction occurs later in the
sequence of events along the activation pathway which has
not yet been reached by the photoactivated intermediate.
In summary, we used molecular dynamics simulations of
mutant constructs of rhodopsin with different activation
phenotypes to shed light on the molecular events that are
likely to precede and trigger larger structural changes along
the GPCR activation path. Two features of GPCR activation
regulated by residues 7.53 and 7.60 emerged: the conforma-
tion of the TM7-HX8 segment and the energy of interaction
between the cytoplasmic ends of TM7 and TM2. Examining
these features in the photoactivated deprotonated intermediate
structure of rhodopsin, we found support for the proposition
that this GPCR structure contains elements of both the
activated and inactive receptor phenotypes, as the TM7-HX8
segment resembled an active-like conformation while the
TM7-TM2 interaction was still intact, resembling an inac-
tive-like state. Similarly, in the experimentally unexplored
construct, Y7.53N/F7.60A (Table 1), the conformational
sampling of the TM7-HX8 segment resembled that of
locked-on Y7.53N (see Figure 1C), yet the TM7-TM2
interaction energy was only partially disrupted (Figure 2C).
Thus, we predict that a Y7.53N/F7.60A 5-HT2C construct
would have an intermediate phenotype between Y7.53N and
the WT, where the F7.60A mutation acts to mitigate the
extreme phenotype of locked-on Y7.53N and brings it closer
to WT levels, similar to the F7.60A rescue of locked-off
Y7.53F (19). Interestingly, in the 2-AR, both the TM7-HX8
segment and the loss of direct interaction between Y7.53
and TM2 suggest that this region adopts an active-like state,
reﬂected by the 2-AR-T4 chimera having an enhanced
afﬁnity for agonists, but not antagonists (7). Given the
complex nature of the structural changes in the properties
of the SM/FM associated with the active and inactive states,
it is not entirely surprising that the crystal structure of the
2-AR includes some active-like elements. Thus, the receptor
has a higher basal activity than rhodopsin; carazolol has a
weak inverse agonist potency, and the chimeric additions
between TM5 and TM6 may affect the adjacent TM7.
SUPPORTING INFORMATION AVAILABLE
Molecular dynamics simulation details, model construc-
tion, essential dynamics analysis, and GPCR numbering
system. This material is available free of charge via the
Internet at http://pubs.acs.org.
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